Category: Supply Chain

Fresenius Kabi recalls drug infusion pumps with leak risk

Fresenius Kabi USA recalled 1,546 large infusion pumps in a Class I recall, the most serious type, because of a risk of leaking products entering the electrical system and shutting down the device. 

How WellSpan turns hospital waste into concrete

WellSpan’s York (Pa.) Hospital has partnered to turn its plastic waste into concrete, which it will use on its next expansion, ABC affiliate WHTM reported April 19.

Hospitals need to align supply chains with clinical input: McKinsey

Less than half of health systems integrate clinicians into supply chain work, and this is barring hospitals from smoothening bumps in their supply chains, according to an April 13 post from McKinsey & Co.

Global Healthcare Exchange names top suppliers, providers

Global Healthcare Exchange named 87 healthcare supplier and provider organizations to the 2022 GHX Millennium Club.

FEMA reimburses Connecticut hospital $2.6M for pandemic supply costs

The Federal Emergency Management Agency benchmarked $2.64 million for Danbury (Conn.) Hospital to reimburse supply costs incurred during the COVID-19 pandemic and “providing food delivery for hospital staff unable to leave the facility during self-quar…

Alabama system leaves supply vendor after 20 years, switches to Medline

DCH Health System, based in Tuscaloosa, Ala., chose Medline as its primary distribution partner April 11 after working with another company for about 20 years. 

$300M to local businesses and counting: 1 supply chain leader's approach to healthcare management

Calvin Wright, senior vice president of supply chain at Texas-based Houston Methodist, prides himself on investing in front-line workers and local businesses. 

Phillips recalls more sleep apnea machines

Philips is recalling 1,088 reworked CPAP and BiPAP machines used for sleep apnea due to the potential for inaccurate or insufficient treatment. 

FDA finds sterilization issues at eye drop plant

The FDA found sterilizations issues at a Global Pharma facility, which manufactured eye drops contaminated with Pseudomonas aeruginosa, CNN reported April 3.

FTC orders Illumina to divest cancer test maker

The Federal Trade Commission on April 3 ordered Illumina to divest cancer test maker Grail, saying the $7.1 billion deal would substantially stifle competition for cancer diagnostics in the U.S.